This continues a strong multi-day rally, with the stock gaining over 20% in the past two sessions alone. The SHIELD contract represents a significant expansion beyond ASTS's core direct-to-cell business into defense applications, potentially opening a new revenue stream. Volume at 2x normal supports genuine institutional interest in this catalyst, and the move substantially outperforms the flat broader market.
This is a permanent link to this specific analysis (ID: 2329)
Back to Dashboard